India and China are the leading exporters of Terbinafine Hydrochloride, accounting for the majority of global shipments, while the United States, Germany, and Brazil represent the largest importers. Terbinafine Hydrochloride prices have remained relatively stable amid consistent demand from pharmaceutical manufacturers in high-income markets. Exports from India have expanded steadily since 2022, reinforcing its position as the dominant supplier, while U.S. imports have grown modestly despite flat domestic production volumes.
Recent Market Dynamics Intelligence
1. **Raw Material Supply**
- The supply of key raw materials for terbinafine hydrochloride has been stable recently. Production at major intermediate manufacturers is operating normally, with no production constraints due to raw material shortages. Overall raw material prices have shown minimal fluctuations, resulting in limited impact on the cost side of terbinafine hydrochloride.
2. **Production Enterprise Dynamics**
- Major domestic producers are maintaining normal operations, with capacity utilization remaining at high levels and stable output. Some enterprises have slight production increase plans to meet order demands.
- Regarding new entrants, there are currently no new production enterprises entering the terbinafine hydrochloride market, and the competitive landscape remains relatively stable.
3. **Market Demand**
- In terms of domestic market demand, with the continuous growth in the pharmaceutical industry's demand for terbinafine hydrochloride, procurement volumes from downstream pharmaceutical companies have increased. Specifically, in the antifungal drug sector, terbinafine hydrochloride, as a key raw material, shows a steady upward trend in demand.
- In international markets, export order volumes have seen a certain increase, primarily exported to Southeast Asia and South Asia, where demand is driven by the development of local pharmaceutical markets.
4. **Price Trends**
- Recently, market prices for terbinafine hydrochloride have generally shown a steady upward trend. Mainstream transaction prices have increased by a certain margin compared to the previous month, with a rise of approximately 3% - 5%. Prices for different specifications vary slightly, with higher-purity products experiencing relatively larger price increases.
5. **Inventory Status**
- Production enterprise inventories are at reasonable levels. Some enterprises have appropriately increased inventory reserves to cope with growing orders. Trader inventories have decreased, and traders' enthusiasm for restocking has increased due to rising market demand.
Analysis and Judgment
1. **Supply Side**: Stable raw material supply and normal production by enterprises ensure that supply capacity can meet current market demand, with no short-term supply shortages expected. However, attention should be paid to new capacity deployment; if new enterprises enter or existing enterprises significantly expand production, it may impact the market supply landscape.
2. **Demand Side**: Growing domestic and international market demand is the main factor driving price increases. The development of the domestic pharmaceutical industry and increased international demand for terbinafine hydrochloride will continue to drive market demand. It is expected that demand will maintain a growth trend for the foreseeable future.
3. **Price Aspect**: Due to demand growth and relatively stable supply, the market supply-demand relationship is tightening, supporting price increases. Although raw material prices have shown little fluctuation, if raw material prices rise in the future, it will further increase the cost of terbinafine hydrochloride, prompting continued price increases.
Forecast
1. **Short-term (1 - 3 months)**: Market prices for terbinafine hydrochloride will continue to show a steady upward trend, with potential increases of 2% - 4%. Market demand continues to grow, production enterprise inventories are reasonable, and supply can meet demand. However, prices, influenced by costs and market sentiment, still have room for slight increases.
2. **Medium-term (3 - 6 months)**: If market demand remains strong and no new capacity is significantly released into the market, prices are expected to rise further, with potential increases of 5% - 8%. Meanwhile, attention should be paid to policy changes affecting the pharmaceutical industry; if policies adjust the production or sales of relevant drugs, it may indirectly impact the market demand and prices of terbinafine hydrochloride.
3. **Long-term (more than 6 months)**: In the long run, market price trends depend on changes in supply-demand balance. If new production enterprises enter the market or existing enterprises significantly expand production, increased supply may lead to price declines; if demand continues to grow and supply cannot keep up, prices will continue to rise. It is expected that long-term prices will fluctuate within a certain range, influenced by a combination of various factors.
Terbinafine Hydrochloride is a white to off-white, crystalline solid with no characteristic odor and low volatility. It is a chiral, substituted allylamine derivative classified as an organic pharmaceutical compound. Primarily used as the active pharmaceutical ingredient (API) in topical and oral antifungal medications, it is not employed as a chemical intermediate in other industrial sectors. Its commercial applications are confined to human pharmaceuticals, specifically for the treatment of dermatophytoses and onychomycosis.
An orally active, antimycotic allylamine related to Naftifine. A specfic inhibitor of squalene epoxidase, a key enzyme in fungal ergosterol biosynthesis. Antifungal.
White crystalline powder. Melting point is 204-208 oC.
This chemical is included in Fine Chemicals - Pharmaceutical Intermediates & APIs. See more about what is Terbinafine Hydrochloride and Terbinafine Hydrochloride SDS information.
Find Terbinafine Hydrochloride supply and Terbinafine Hydrochloride suppliers on Guidechem to meet your sourcing needs from 854 trusted and certifedsuppliers.
Guidechem assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness, fitness for purpose or timeliness.